Drug Trial Radar · NCT06006689
Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
228
Actual
Start
Sep 15, 2023
Primary completion
Apr 16, 2025
Study completion Apr 16, 2025
Sponsor
- Lead sponsor
- Tasly Pharmaceutical Group Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Aug 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy and Safety of QiShen YiQi Dripping Pills in the treatment of Diabetic Kidney Disease (syndrome of Qi deficiency with blood stasis)
Conditions
- Diabetic Kidney Disease
Interventions
Qishen Yiqi Dripping Pills placebo 3 bagsDrug
Qishen Yiqi Dripping Pills placebo contain Qishen Yiqi dripping pills placebo 3 bags(0.52g dripping pills placebo per bag),take orally after meals, 3 times a day for 12weeks
Low dose Qishen Yiqi Dripping Pills 3 bagsDrug
Low dose Qishen Yiqi Dripping Pills contain Qishen Yiqi dripping pills 2 bags(0.52g dripping pills per bag) and Qishen Yiqi dripping pills placebo 1 bag(0.52g dripping pills placebo per bag),take orally after meals, 3 times a day for 12weeks
High dose Qishen Yiqi Dripping Pills 3 bagsDrug
High dose Qishen Yiqi Dripping Pills contain Qishen Yiqi dripping pills 3 bags(0.52g dripping pills per bag),take orally after meals, 3 times a day for 12weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in UACR(urinary albumin ⁃ to ⁃ creatinine ratio).Time frame: Baseline to weeks 4, 8 and 12
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Dongzhimen Hospital of Beijing University of Chinese Medicine
Beijing, Beijing Municipality, China
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China
The Affiliated TCM Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Hebei Province Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, China
Heilongjiang Academy of Traditional Chinese Medicine (Heilongjiang Provincial Hospital of Traditional Chinese Medicine)
Harbin, Heilongjiang, China
Kaifeng Hospital of Traditional Chinese Medicine
Kaifeng, Henan, China
Luoyang Third People's Hospital
Luoyang, Henan, China
Sanmenxia Central Hospital
Sanmenxia, Henan, China
The First Hospital of Hunan University of Chinese Medicine
Changsha, Hunan, China
Shananxi Province Hospital of Traditional Chinese Medicine
Xi'an, Shananxi, China
Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China
Hangzhou hospital of traditional Chinese medicine
Hangzhou, Zhejiang, China
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.